2015-02-25 - LifeMap Sciences Partners with Toldot Genetics to Support Next Generation Sequencing Variant Analysis Commercialization

LifeMap Sciences, Inc. (LifeMap), a subsidiary of BioTime, Inc., announced today a commercial partnership agreement with Toldot Genetics, LTD (Toldot), a subsidiary of BATM Advanced Communications, Ltd. LifeMap’s GeneCards Suite, comprised of the company’s integrated biomedical knowledgebase and premium analysis tools, will optimize Toldot’s next generation sequencing (NGS) data analysis capabilities by powering its algorithm-based tools for assigning genetic variations derived from whole genome and exome sequencing, to clinical conditions in order to improve biomedical research. LifeMap will also promote Toldot’s products and offer them to its large user base of life scientists in academia, research hospitals, and biopharma.